Is lithium in a class of its own? A brief profile of its clinical use

References

• Cogen PH, Whybrow PC. Lithium: a fascinating element in neuropsychiatry. Bauer M, Grof P, Muller-Oerlinghausen B, Lithium in neuropsychiatry: the comprehensive guide. Abingdon, UK: Informa, 2006:3–7.
   Google Scholar
• Gershon S, Chengappa KNR, Malhi GS. Lithium specificity in bipolar illness: a classic agent for the classic disorder. Bipolar Disord 2009; 11:34–44.
   PubMed Web of Science ®Google Scholar
• Ghaemi SN. Why antidepressants are not antidepressants: STEP-BD, STAR*D, and the return of neurotic depression. Bipolar Disord 2008; 10:957–68.
   PubMed Web of Science ®Google Scholar
• National Health and Medical Research Council. A guide to the development, implementation and evaluation of clinical practice guidelines. Canberra: Commonwealth of Australia, 1998.
   Google Scholar
• Cade JF, Malhi GS. Cade's lithium. Acta Neuropsychiatr 2007; 19:125–126.
   Web of Science ®Google Scholar
• Schou M, Juel-Nielsen N, Stromgren E, Voldby H. The treatment of manic psychoses by the administration of lithium salts. J Neurol Neurosurg Psychiatry 1954; 17:250–260.
   PubMed Web of Science ®Google Scholar
• Maggs R. Treatment of manic illness with lithium carbonate. Br J Psychiatry 1963; 109:59–65.
   Web of Science ®Google Scholar
• Goodwin FK, Murphy DL, Bunney WE Jr. Lithium-carbonate treatment in depression and mania. A longitudinal double-blind study. Arch Gen Psychiatry 1969; 21:486–496.
   PubMed Web of Science ®Google Scholar
• Stokes PE, Shamoian CA, Stoll PM, Patton MJ. Efficacy of lithium as acute treatment of manic-depressive illness. Lancet 1971; 1:1319–1325.
   PubMed Web of Science ®Google Scholar
• Baldessarini RJ, Tondo L. Does lithium treatment still work? Evidence of stable responses over three decades. Arch Gen Psychiatry 2000; 57:187–190.
   PubMed Web of Science ®Google Scholar
• Prien RF, Caffey EM Jr, Klett CJ. A comparison of lithium carbonate and chlorpromazine in the treatment of excited schizo-affectives. Report of the Veterans Administration and National Institute of Mental Health collaborative study group. Arch Gen Psychiatry 1972; 27:182–189.
   PubMed Web of Science ®Google Scholar
• Prien RF, Caffey EM Jr, Klett CJ. Comparison of lithium carbonate and chlorpromazine in the treatment of mania. Report of the Veterans Administration and National Institute of Mental Health Collaborative Study Group. Arch Gen Psychiatry 1972; 26:146–153.
   PubMed Web of Science ®Google Scholar
• Braden W, Fink EB, Qualls CB, Ho CK, Samuels WO. Lithium and chlorpromazine in psychotic inpatients. Psychiatry Res 1982; 7:69–81.
   PubMed Web of Science ®Google Scholar
• Bowden CL, Grunze H, Mullen J . A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder. J Clin Psychiatry 2005; 66:111–121.
   PubMed Web of Science ®Google Scholar
• Yatham LN, Grossman F, Augustyns I, Vieta E, Ravindran A. Mood stabilisers plus risperidone or placebo in the treatment of acute mania. International, double-blind, randomised controlled trial. Br J Psychiatry 2003; 182:141–147.
   PubMed Web of Science ®Google Scholar
• Sachs GS, Grossman F, Ghaemi SN, Okamoto A, Bowden CL. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety. Am J Psychiatry 2002; 159:1146–1154.
   PubMed Web of Science ®Google Scholar
• Yatham LN, Paulsson B, Mullen J, Vagero AM. Quetiapine versus placebo in combination with lithium or divalproex for the treatment of bipolar mania. J Clin Psychopharmacol 2004; 24:599–606.
   PubMed Web of Science ®Google Scholar
• Tohen M, Chengappa KN, Suppes T . Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. Arch Gen Psychiatry 2002; 59:62–69.
   PubMed Web of Science ®Google Scholar
• Scherk H, Pajonk FG, Leucht S. Second-generation antipsychotic agents in the treatment of acute mania: a systematic review and meta-analysis of randomized controlled trials. Arch Gen Psychiatry 2007; 64:442–455.
   PubMed Web of Science ®Google Scholar
• Perlis RH, Welge JA, Vornik LA, Hirschfeld RM, Keck PE Jr. Atypical antipsychotics in the treatment of mania: a meta-analysis of randomized, placebo-controlled trials. J Clin Psychiatry 2006; 67:509–516.
   PubMed Web of Science ®Google Scholar
• Valenti M, Benabarre A, Garcia-Amador M, Molina O, Bernardo M, Vieta E. Electroconvulsive therapy in the treatment of mixed states in bipolar disorder. Eur Psychiatry 2008; 23:53–56.
   PubMed Web of Science ®Google Scholar
• Segal J, Berk M, Brook S. Risperidone compared with both lithium and haloperidol in mania: a double-blind randomized controlled trial. Clin Neuropharmacol 1998; 21:176–180.
   PubMed Web of Science ®Google Scholar
• Carney SM, Goodwin GM. Lithium: a continuing story in the treatment of bipolar disorder. Acta Psychiatr Scand 2005; 111:7–12.
   Web of Science ®Google Scholar
• Bhagwagar Z, Goodwin GM. The role of lithium in the treatment of bipolar depression. Clin Neurosci Res 2002; 2:222–227.
   Web of Science ®Google Scholar
• Yatham LN, Kennedy SH, Schaffer A . Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disord 2009; 11:225–255.
   PubMed Web of Science ®Google Scholar
• Malhi GS, Adams D, Lampe L . Clinical practice recommendations for bipolar disorder. Acta Psychiatr Scand 2009; 119:27–46.
   Web of Science ®Google Scholar
• Fieve RR, Platman SR, Plutchik RR. The use of lithium in affective disorders. II. Prophylaxis of depression in chronic recurrent affective disorder. Am J Psychiatry 1968; 125:492–498.
   PubMed Web of Science ®Google Scholar
• Greenspan K, Schildkraut JJ, Gordon EK, Baer L, Aronoff MS, Durell J. Catecholamine metabolism in affective disorders. 3. MHPG and other catecholamine metabolites in patients treated with lithium carbonate. J Psychiatr Res 1970; 7:171–183.
   PubMed Web of Science ®Google Scholar
• Goodwin FK, Murphy DL, Dunner DL, Bunney WE Jr. Lithium response in unipolar versus bipolar depression. Am J Psychiatry 1972; 129:44–47.
   PubMed Web of Science ®Google Scholar
• Noyes R Jr, Dempsey GM. Lithium treatment of depression. Dis Nerv Syst 1974; 35:573–576.
   PubMedGoogle Scholar
• Mendels J. Lithium in the treatment of depression. Am J Psychiatry 1976; 133:373–378.
   PubMed Web of Science ®Google Scholar
• Baron M, Gershon ES, Rudy V, Jonas WZ, Buchsbaum M. Lithium carbonate response in depression. Prediction by unipolar/bipolar illness, average-evoked response, catechol-O-methyl transferase, and family history. Arch Gen Psychiatry 1975; 32:1107–1111.
   PubMed Web of Science ®Google Scholar
• Donnelly EF, Goodwin FK, Waldman IN, Murphy DL. Prediction of antidepressant responses to lithium. Am J Psychiatry 1978; 135:552–556.
   PubMed Web of Science ®Google Scholar
• Malhi GS, Mitchell PB, Salim S. Bipolar depression: management options. CNS Drugs 2003; 17:9–25.
   PubMed Web of Science ®Google Scholar
• Young AH, Carlsson A, Olausson B, Paulsson B, Brecher M. A double-blind, placebo-controlled study with acute and continuation phase of quetiapine and lithium in adults with bipolar depression (Embolden I). Eur Psychiatry 2008; 23:S239.
   Web of Science ®Google Scholar
• Heit F, Nemeroff CB. Lithium augmentation of antidepressants in treatment-refractory depression. J Clin Psychiatry 1998; 59:28–33.
   PubMed Web of Science ®Google Scholar
• Ebert D, Jaspert A, Murata H, Kaschka WP. Initial lithium augmentation improves the antidepressant effects of standard TCA treatment in non-resistant depressed patients. Psychopharmacology 1995; 118:223–225.
   PubMed Web of Science ®Google Scholar
• Malhi GS, Adams D, Berk M. Medicating mood with maintenance in mind: bipolar depression pharmacotherapy. Bipolar Disord 2009; 11:55–76.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry 2002; 159:4–50.
   Web of Science ®Google Scholar
• Burgess S, Geddes J, Hawton K, Townsend E, Jamison K, Goodwin G. Lithium for maintenance treatment of mood disorders. Cochrane Database Syst Rev 2001; (3):CD003013.
   Google Scholar
• Geddes JR, Burgess S, Hawton K, Jamison K, Goodwin GM. Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials. Am J Psychiatry 2004; 161:217–222.
   PubMed Web of Science ®Google Scholar
• Smith LA, Cornelius V, Warnock A, Bell A, Young AH. Effectiveness of mood stabilizers and antipsychotics in the maintenance phase of bipolar disorder: a systematic review of randomized controlled trials. Bipolar Disord 2007; 9:394–412.
   PubMed Web of Science ®Google Scholar
• Geddes JR. BALANCE: initial results and methodological aspects of trials of maintenance treatments (Abstract 17). Abstracts from Eighth International Conference on Bipolar Disorder, Pittsburgh, USA. Bipolar Disord 2009; 11:6.
   Web of Science ®Google Scholar
• Tondo L, Baldessarini RJ, Floris G. Long-term clinical effectiveness of lithium maintenance treatment in types I and II bipolar disorders. Br J Psychiatry 2001; 41 (Suppl):S184–s190.
   Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual for mental disorders, 4th edn, text revision (DSM-IV-TR). Washington, DC: American Psychiatric Association, 2000.
   Google Scholar
• Berk M, Dodd S, Malhi GS. ‘Bipolar missed states’: the diagnosis and clinical salience of bipolar mixed states. Aust N Z J Psychiatry 2005; 39:215–221.
   PubMed Web of Science ®Google Scholar
• Tondo L, Hennen J, Baldessarini RJ. Rapid-cycling bipolar disorder: effects of long-term treatments. Acta Psychiatr Scand 2003; 108:4–14.
   PubMed Web of Science ®Google Scholar
• Calabrese J, Shelton M, Rapport D. A 20-month, double-blind, maintenance trial of lithium vs. divalproex in rapid-cycling bipolar disorder. Am J Psychiatry 2005; 162:2152–2161.
   PubMed Web of Science ®Google Scholar
• Calabrese JR, Delucchi GA. Spectrum of efficacy of valproate in 55 patients with rapid-cycling bipolar disorder. Am J Psychiatry 1990; 147:431–434.
   PubMed Web of Science ®Google Scholar
• Calabrese JR, Rapport DJ, Kimmel SE, Reece B, Woyshville MJ. Rapid cycling bipolar disorder and its treatment with valproate. Can J Psychiatry 1993; 38:S57–61.
   Web of Science ®Google Scholar
• Kupka RW, Luckenbaugh DA, Post RM, Leverich GS, Nolen WA. Rapid and non-rapid cycling bipolar disorder: a meta-analysis of clinical studies. J Clin Psychiatry 2003; 64:1483–1494.
   PubMed Web of Science ®Google Scholar
• Muzina DJ, Bauer M, Calabrese JR. Lithium in rapid cycling bipolar disorder. Bauer M, Grof P, Muller-Oerlinghausen B, Lithium in neuropsychiatry: the comprehensive guide. Abingdon, UK: Informa Healthcare, 2006:145–155.
   Google Scholar
• Muzina DJ. Pharmacologic treatment of rapid cycling and mixed states in bipolar disorder: an argument for the use of lithium. Bipolar Disord 2009; 11:84–91.
   PubMed Web of Science ®Google Scholar
• Denicoff KD, Smith-Jackson EE, Disney ER, Ali SO, Leverich GS, Post RM. Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorder. J Clin Psychiatry 1997; 58:470–478.
   PubMed Web of Science ®Google Scholar
• Mendels J, Secunda SK, Dyson WL. A controlled study of the antidepressant effects of lithium carbonate. Arch Gen Psychiatry 1972; 26:154–157.
   PubMed Web of Science ®Google Scholar
• Watanabe S, Ishino H, Otsuki S. Double-blind comparison of lithium carbonate and imipramine in treatment of depression. Arch Gen Psychiatry 1975; 32:659–668.
   PubMed Web of Science ®Google Scholar
• Worrall EP, Moody JP, Peet M . Controlled studies of the acute antidepressant effects of lithium. Br J Psychiatry 1979; 135:255–262.
   PubMed Web of Science ®Google Scholar
• Khan MC. Lithium carbonate in the treatment of acute depressive illness. Biblioth Psychiatr 1981; 161:244–248.
   Google Scholar
• Arieli A, Lepkifker E. The antidepressant effect of lithium. Curr Dev Psychopharmacol 1981; 6:165–190.
   PubMedGoogle Scholar
• Khan MC, Wickham EA, Reed JV. Lithium versus placebo in acute depression: a clinical trial. Int Clin Psychopharmacol 1987; 2:47–54.
   PubMed Web of Science ®Google Scholar
• Souza FG, Goodwin GM. Lithium treatment and prophylaxis in unipolar depression: a meta-analysis. Br J Psychiatry 1991; 158:666–675.
   PubMed Web of Science ®Google Scholar
• Kupfer DJ, Pickar D, Himmelhoch JM, Detre TP. Are there two types of unipolar depression? Arch Gen Psychiatry 1975; 32:866–871.
   PubMed Web of Science ®Google Scholar
• Bauer M, Whybrow PC, Angst J, Versiani M, Moller H-J, WFSBP Task Force on Treatment Guidelines for Unipolar Depressive Disorders. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: acute and continuation treatment of major depressive disorder. World J Biol Psychiatry 2002; 3:5–43.
   PubMedGoogle Scholar
• Malhi GS, Adams D, Porter R . Clinical practice recommendations for depression. Acta Psychiatr Scand 2009; 119:8–26.
   Web of Science ®Google Scholar
• Bschor T, Bauer M. Efficacy and mechanisms of action of lithium augmentation in refractory major depression. Curr Pharm Des 2006; 12:2985–2992.
   PubMed Web of Science ®Google Scholar
• Bauer M, Forsthoff A, Baethge C . Lithium augmentation therapy in refractory depression: update 2002. Eur Arch Psychiatry Clin Neurosci 2003; 253:132–139.
   PubMed Web of Science ®Google Scholar
• Fava M, Rush AJ. Current status of augmentation and combination treatments for major depressive disorder: a literature review and a proposal for a novel approach to improve practice. Psychother Psychosom 2006; 75:139–153.
   PubMed Web of Science ®Google Scholar
• Malhi GS, Ng F, Berk M. Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression. Aust N Z J Psychiatry 2008; 42:346–349.
   PubMed Web of Science ®Google Scholar
• Bauer M, Crossley NA, Gerber S, Bschor T. The acute antidepressive effects of lithium: from monotherapy to augmentation therapy in major depression. Bauer M, Grof P, Muller-Oerlinghausen B, Lithium in neuropsychiatry: the comprehensive guide. Abingdon, UK: Informa, 2006:109–127.
   Google Scholar
• Maj M. Lithium prophylaxis of schizoaffective disorders: a prospective study. J Affect Disord 1988; 14:129–135.
   PubMed Web of Science ®Google Scholar
• Brockington IF, Kendell RE, Kellett JM, Curry SH, Wainwright S. Trials of lithium, chlorpromazine and amitriptyline in schizoaffective patients. Br J Psychiatry 1978; 133:162–168.
   PubMed Web of Science ®Google Scholar
• Brockington IF, Wainwright S, Kendell RE. Manic patients with schizophrenic or paranoid symptoms. Psychol Med 1980; 10:73–83.
   PubMed Web of Science ®Google Scholar
• Miller FT, Libman H. Lithium carbonate in the treatment of schizophrenia and schizo-affective disorder: review and hypothesis. Biol Psychiatry 1979; 14:705–710.
   PubMed Web of Science ®Google Scholar
• Prien RF, Caffey EM Jr, Klett CJ. Factors associated with treatment success in lithium carbonate prophylaxis. Report of the Veterans Administration and National Institute of Mental Health collaborative study group. Arch Gen Psychiatry 1974; 31:189–192.
   PubMed Web of Science ®Google Scholar
• Leucht S, Kissling W, McGrath J. Lithium for schizophrenia. Cochrane Database Syst Rev 2007; (3):CD003834.
   Web of Science ®Google Scholar
• Guze SB, Robins E. Suicide and primary affective disorders. Br J Psychiatry 1970; 117:437–438.
   PubMed Web of Science ®Google Scholar
• Bradvik L, Mattisson C, Bogren M, Nettelbladt P. Long-term suicide risk of depression in the Lundby cohort 1947–1997: severity and gender. Acta Psychiatr Scand 2008; 117:185–191.
   PubMed Web of Science ®Google Scholar
• Coppen A, Standish-Barry H, Bailey J, Houston G, Silcocks P, Hermon C. Does lithium reduce the mortality of recurrent mood disorders? J Affect Disord 1991; 23:1–7.
   PubMed Web of Science ®Google Scholar
• Guzzetta F, Tondo L, Centorrino F, Baldessarini RJ. Lithium treatment reduces suicide risk in recurrent major depressive disorder. J Clin Psychiatry 2007; 68:380–383.
   PubMed Web of Science ®Google Scholar
• Muller-Oerlinghausen B, Ahrens B, Grof E . The effect of long-term lithium treatment on the mortality of patients with manic-depressive and schizoaffective illness. Acta Psychiatr Scand 1992; 86:218–222.
   PubMed Web of Science ®Google Scholar
• Baldessarini RJ, Tondo L, Davis P, Pompili M, Goodwin FK, Hennen J. Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review. Bipolar Disord 2006; 8:625–639.
   PubMed Web of Science ®Google Scholar
• Cipriani A, Pretty H, Hawton K, Geddes JR. Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials. Am J Psychiatry 2005; 162:1805–1819.
   PubMed Web of Science ®Google Scholar
• Berk M. Neuroprogression: pathways to progressive brain changes in bipolar disorder. Int J Neuropsychopharmcol 2009; 12:441–445.
   PubMed Web of Science ®Google Scholar
• Manji HK, Duman RS. Impairments of neuroplasticity and cellular resilience in severe mood disorders: implications for the development of novel therapeutics. Psychopharmacol Bull 2001; 35:5–49.
   PubMedGoogle Scholar
• Cade JFJ. Lithium salts in the treatment of psychotic excitement. Med J Aust 1949; 2:349–352.
   PubMed Web of Science ®Google Scholar
• Machado-Vieira R, Manji HK, Zarate CA Jr. The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis. Bipolar Disord 2009; 11:92–109.
   PubMed Web of Science ®Google Scholar
• Kempton MJ, Geddes JR, Ettinger U, Williams SC, Grasby PM. Meta-analysis, database, and meta-regression of 98 structural imaging studies in bipolar disorder. Arch Gen Psychiatry 2008; 65:1017–1032.
   PubMed Web of Science ®Google Scholar
• Hirschfeld RMA. Guideline watch (November 2005): practice guideline for the treatment of patients with bipolar disorder, 2nd edn. Focus 2007; 5:34–39.
   Google Scholar
• National Institute for Health and Clinical Excellence. Bipolar disorder: the management of bipolar disorder in adults, children and adolescents, in primary and secondary care: clinical guideline 38. London: NHS, 2006.
   Google Scholar
• Ng F, Mammen OK, Wilting I . The International Society for Bipolar Disorders (ISBD) consensus guidelines for the safety monitoring of bipolar disorder treatments. Bipolar Disord 2009; 11:559–595.
   PubMed Web of Science ®Google Scholar
• Royal Australian and New Zealand College of Psychiatrists. Australian and New Zealand clinical practice guidelines for the treatment of bipolar disorder. Aust N Z J Psychiatry 2004; 38:280–305.
   PubMed Web of Science ®Google Scholar
• Grunze H, Kasper S, Goodwin G, Bowden C, Moller HJ, WFSBP Taskforce on Treatment Guidelines for Bipolar Disorders. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part III: maintenance treatment. World J Biol Psychiatry 2004; 5:120–135.
   PubMed Web of Science ®Google Scholar
• Grunze H, Kasper S, Goodwin G . The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part II: treatment of mania. World J Biol Psychiatry 2003; 4:5–13.
   PubMed Web of Science ®Google Scholar
• Grunze H, Kasper S, Goodwin G . The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders. Part I: treatment of bipolar depression. World J Biol Psychiatry 2002; 3:115–124.
   PubMedGoogle Scholar
• National Institute for Health and Clinical Excellence. Depression in children and young people: clinical guideline 28. London: NHS, 2005.
   Google Scholar
• Malhi GS, Adams D. Are guidelines in need of CPR? The development of clinical practice recommendations (CPR) for mood disorders. Acta Psychiatr Scand 2009; 119:5–7.
   Web of Science ®Google Scholar
• MIMS Online. MIMS Australia. Sydney: MIMS Australia Pty Ltd & CMPMedica Australia Pty Ltd, 2009. [cited 28 January 2009.] Available from URL: http://mims.hcn.net.au.ezproxy2.library.usyd.edu.au/ifmx-nsapi/mims-data/?MIval=2MIMS_ssearch.
   Google Scholar
• ACOG Committee on Practice Bulletins–Obstetrics. ACOG Practice Bulletin: clinical management guidelines for obstetrician– gynecologists number 92, April 2008 (replaces practice bulletin number 87, November 2007). Use of psychiatric medications during pregnancy and lactation. Obstet Gynecol 2008; 111:1001–1020.
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Clinical Excellence. Antenatal and postnatal mental health: clinical Guideline 45. London: NHS, 2007.
   Google Scholar
• Malhi GS, Goodwin GM. The ‘rise and fall’ of mood stabilizers. Aust N Z J Psychiatry 2007; 41:779–783.
   PubMed Web of Science ®Google Scholar